CURE INNOVATIONS LLC (EIN 463840398) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

STANLEY CHOY

Phone

2034702720

Tax Period

2023-07-01 to 2024-06-30

CURE INNOVATIONS LLC, founded in 2013, is a small nonprofit in the Youth Development sector that reported $421K in total revenue in fiscal year 2023. Expenses of $611K exceeded revenue, resulting in a 45% operating deficit.

Mission

THE ORGANIZATION WAS FORMED TO MANAGE CURE INNOVATION COMMONS, AN INCUBATOR FOR BIOSCIENCE AND OTHER TECHNOLOGIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $0

Other Revenue $420,556

TOTAL REVENUE $420,556

Expense Breakdown

Grants Paid $0

Salaries & Benefits $249,763

Fundraising Expenses $0

Program Expenses $570,464

Other Expenses $361,461

TOTAL EXPENSES $611,224

Year-over-Year Comparison

	2023	2022	Change
Revenue	$420,556	$437,421	0.0%
Expenses	$611,224	$563,287	+0.1%
Net Income	$-190,668	$-125,866	+0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$80,167

Total Directors

$80,167

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DAWN HOCEVAR	PRESIDENT &	10.00	Officer Director	$0	$0	$41,667
STANLEY CHOY	CHAIR & TREA	0.30	Officer Director	$0	$0	$38,500
PAUL HUGHES	SECRETARY	0.10	Officer Director	$0	$0	$0
MARK ADAMS	DIRECTOR	0.10	Director	$0	$0	$0
ABHIJIT BANERJEE	DIRECTOR	0.10	Director	$0	$0	$0
ROBERT BETTIGOLE	DIRECTOR	0.10	Director	$0	$0	$0
JEAN-MICHEL BOERS	DIRECTOR	0.10	Director	$0	$0	$0
KAT KAYSER-BRICKER	DIRECTOR	0.10	Director	$0	$0	$0
SENG H CHENG	DIRECTOR	0.10	Director	$0	$0	$0
PAUL FONTEYNE	DIRECTOR	0.10	Director	$0	$0	$0
JOSH GEBALLE	DIRECTOR	0.10	Director	$0	$0	$0
JODIE GILLON	DIRECTOR	0.10	Director	$0	$0	$0
JOHN G HOUSTON	DIRECTOR	0.10	Director	$0	$0	$0
RAJA MANGIPUDY	DIRECTOR	0.10	Director	$0	$0	$0
DAVID I SCHEER	DIRECTOR	0.10	Director	$0	$0	$0
JACKIE SCHUMACHER	DIRECTOR	0.10	Director	$0	$0	$0
ERIKA SMITH	DIRECTOR	0.10	Director	$0	$0	$0
J DORMER STEPHEN	DIRECTOR	0.10	Director	$0	$0	$0
MATT STOREYGARD	DIRECTOR	0.10	Director	$0	$0	$0
MIKE STOW	DIRECTOR	0.10	Director	$0	$0	$0
CARTER WINSTANLEY	DIRECTOR	0.10	Director	$0	$0	$0
KAILE ZAGGER	DIRECTOR	0.10	Director	$0	$0	$0
KIMBERLY NASH	OPERATING DI	40.00	Highest	$105,000	$0	$105,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2024	$420,556	$611,224	$4,431,109	$-190,668
2023	$437,421	$563,287	$4,513,049	$-125,866
2022	$312,505	$528,675	$4,610,501	$-216,170
2021	$352,861	$479,867	$4,823,325	$-127,006
2020	$366,769	$434,892	$4,881,311	$-68,123
2019	$307,652	$351,889	$4,703,102	$-44,237
2018	$344,688	$391,939	$4,700,811	$-47,251

CURE INNOVATIONS LLC